Search

You searched for "consultations"

1963 results found

Happy hour

3 August 2023 |
Welcome Eye News Aug/Sep 2023, your bi-monthly tonic for a much-needed happy hour. In the current climate of challenge across all fronts, there’s no better time to reach out for the professional equivalent of a cheery cup in the company...

The 2020 Milgram Experiment

19 May 2020 | | Ophthalmology, Optometry, COVID-19, ONLINE EXCLUSIVE ARTICLES
Will ophthalmology recover from COVID-19? Learning Curve columnist Gwyn Samuel Williams shares his thoughts on the developing impact of the pandemic “It’s busy today,” the nurse in green chuckles. “There are six patients I think.” Six. This clinic is designed...

How to get out of chairing Zoom Meetings

1 August 2022 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
One of the biggest changes brought on by far over the past two years is the emergence of Zoom, Teams, or a similar virtual platform for conducting the meetings we all know and love. There are many advantages, and also...

The ghost of Christmas present

1 December 2022 | | Ophthalmology
“Ah, youth is wasted on the wrong people.” Some will recognise this as one of the many brilliant quotes from what is considered to be the best Christmas movie ever – Frank Capra’s tear-jerker It’s a Wonderful Life (1946), although...

Managing a patient with ptosis

1 August 2015 | | Oculoplastics, Orbit
A 50-year-old male patient is referred from the Accident & Emergency department with a history of ptosis. How will you manage this patient? Mr Bertie Fernando Clinical management Clinical management starts with a sound clinical history. Current history The history...

More sensitive visual acuity test for age-related macular degeneration

1 October 2016 | | Retina / Uvea / Vitreous
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Primarily associated with ageing, genetic factors and lifestyle choices such as smoking also play a contributory role. Patients with early AMD, characterised by the development of...

In conversation with Clare Abbott (ECLO)

3 October 2022 | | Ophthalmology, Optometry
Rosalyn Painter spoke to Clare Abbott, a member of the Eye Clinic Liaison Officer (ECLO) team at Oxford Eye Hospital, about her day-to-day job as an ECLO, how the role can help patients, and the ongoing importance of their work....

The last three patients: general practice (Patient One)

3 April 2023 | | Ophthalmology
Professor Jonathan Rees is an Emeritus Professor of Dermatology at the University of Edinburgh (2020). He held the Grant Chair of Dermatology in Edinburgh from 2000 to 2020, and before that the Chair of Dermatology in Newcastle from 1992 to...

OXSIGHT Onyx – A sight-enhancing wearable

5 April 2022 | | Ophthalmology, Optometry
The Onyx is a newly-released (late 2021) wearable with a powered magnifier to assist those with central vision impairment. Unlike the previously covered wearable devices, this enhances existing sight. The unit can either be held against the eyes when needed,...

COMPlog – Electronic visual lane software

4 February 2021 | | Ophthalmology, Optometry
COMPlog is software designed to replace physical Snellen and LogMAR charts. We have been using COMPlog since 2017 in the unit where I work. Some readers may find our experience, and reasons for choosing this product, interesting. This article is...

Can e-learning help bridge the ophthalmology teaching gap?

1 February 2022 | | Ophthalmology
The authors ask whether e-learning can help to address the current lack of ophthalmology teaching in the undergraduate curriculum. Studies among the United Kingdom, Australasian, Canadian and Asian medical schools have found that students on average spent just over a...

Recurrent corneal erosions secondary to isotretinoin use

7 December 2020 | | Ophthalmology, Cornea / External Eye Disease
Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations, as shown in Table 1 [3]. These side-effects need...